Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists seek avian flu tests to assess emerging strains
"It is critical that we seek to better understand the risks associated with these potentially harmful viruses" - Professor Lonneke Vervelde.

Outcomes could support ongoing global surveillance measures.

Scientists are seeking to develop tissue tests that can identify mild strains of avian influenza that have the potential to become more dangerous.

Led by the University of Edinburgh’s Roslin Institute, the project will focus on both mild and more severe strains associated with recent outbreaks.

The results could identify the risks linked to emerging strains, so those with a high potential for disease can be better managed. Scientists say the outcomes could also support ongoing global surveillance measures for avian flu.

“We know that mild H5 H7 strains can become very dangerous, but it is becoming clear that other mild strains are, to our surprise, becoming more virulent,” explained Professor Lonneke Vervelde of the Roslin Institute. “It is critical that we seek to better understand the risks associated with these potentially harmful viruses.”

In the project, researchers will seek to discover the biological factors that cause some low-risk avian flu strains to become more dangerous. They will do this by manipulating the RNA of some influenza strains in the laboratory to identify the genetic code linked to the risk of harmful disease.

The team will also assess how these viruses interact with wild birds and poultry to understand the potential risks from viruses that pass between the two groups. Experiments will test the impact of the strains on various tissues to check for signs of severe disease than would be expected in domestic or wild birds.

The project is a collaboration with Royal GD Animal Health in the Netherlands, the University of Veterinary Medicine, Hannover, Germany, the National Veterinary Research Institute of Poland, and the National Food Chain Safety Office Veterinary Diagnostic Directorate in Hungary.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.